82189

A Randomized Phase II Trial Investigating the Addition of Carboplatin to Neoadjuvant Therapy for Triple-Negative and HER2-Positive Early Breast Cancer(GeparSixto - GBG 66)


More by Gunter Von Minckwitz :
Presentations
  1. Meeting: 2012 ASCO Annual Meeting
    Session: Breast Cancer - HER2/ER (Oral Abstract Session)
    Discussant: Gunter Von Minckwitz